This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep;6(5):400.

Comment

Kim Margolin. Curr Oncol Rep. 2004 Sep.

. 2004 Sep;6(5):400.

No abstract available

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma.
Danson S, Lorigan P, Arance A, Clamp A, Ranson M, Hodgetts J, Lomax L, Ashcroft L, Thatcher N, Middleton MR. Danson S, et al. J Clin Oncol. 2003 Jul 1;21(13):2551-7. doi: 10.1200/JCO.2003.10.039. J Clin Oncol. 2003. PMID: 12829675 Clinical Trial.